Experts discuss future opioid lawsuit strategies, lawsuits’ impact on manufacturers
From the article:
Last month, Johnson & Johnson was ordered to pay more than $572 million in damages for its role in the opioid epidemic in Oklahoma. Purdue Pharma previously agreed to pay the state $270 million, and Teva Pharmaceuticals agreed to pay Oklahoma $85 million, rather than face trial.
The recent judgment against Johnson & Johnson may not be indicative of how future lawsuits against opioid manufacturers are resolved, experts told Healio Primary Care. However, some said the recent flurry of legal action may ultimately result in the development of opioid formulations that are safer for patients.
Healio Primary Care spoke with several legal and clinical leaders about the health and legal implications of the Oklahoma lawsuit and the numerous others that have yet to be decided.
Read more here.